This site is intended for healthcare professionals
Login
Register
Medical Education
Specialty
Drugs
News
Congresses
Search
Menu
Medical Education
Specialty
Drugs
News
Congresses
Home
/
Medical Education
/
Psoriasis Academy
/
EADV 2021 videos
/
Why was tildrakizumab evaluated for treating psori...
Why was tildrakizumab evaluated for treating psoriasis in the POSITIVE study?
The Academy
Patient-centred care in psoriasis
Psoriasis Management
Psoriasis Treatment
Key evidence on psoriasis treatments
Psoriasis Guidelines
Expert opinion – patient wellbeing in psoriasis
Feedback
Bookmark
Bookmarked
Top
